Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2013 | 12-2006 | |
Assets | ||
Current Assets | ||
Cash & Cash Equivalents | 1,987 | N/A |
TOTAL | $2,448 | $N/A |
Non-Current Assets | ||
PPE Net | 1,404 | N/A |
Other Non-Current Assets | 283 | 0 |
TOTAL | $1,687 | $N/A |
Total Assets | $4,135 | $N/A |
Liabilities | ||
Current Liabilities | ||
Short Term Debt | 708 | N/A |
Accounts payable and accrued liabilities | 1,414 | 0 |
Accrued Expenses | 866 | N/A |
Other current liabilities | 24 | N/A |
TOTAL | $3,153 | $N/A |
Non-Current Liabilities | ||
Long Term Debt | 2,274 | N/A |
Deferred Revenues | 141 | N/A |
Other Non-Current Liabilities | 67 | 0 |
TOTAL | $2,478 | $N/A |
Total Liabilities | $5,631 | $N/A |
Shareholders' Equity | ||
Common Shares | 1 | N/A |
Retained earnings | -41,921 | N/A |
Other shareholders' equity | 39,958 | 0 |
TOTAL | $-1,496 | $N/A |
Total Liabilities And Equity | $4,135 | $0 |